Quarterly Transactions Made in Relmada Therapeutics, Inc. (RLMD)
This table provides information about the institutional ownership of Relmada Therapeutics, Inc. (RLMD). The information is specifically focused on institutions that hold shares of RELMADA THERAPEUTICS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 895,968 | 1,043,374 | 1,939,342 | 649,770 | 1,164,839 | 1,814,609 | 124,733 | |
| Q4 2021 | 3,831,729 | 7,819,290 | 11,651,019 | 269,128 | 504,224 | 773,352 | 10,877,667 | |
| Q1 2022 | 4,142,620 | 992,837 | 5,135,457 | 1,300,298 | 1,509,783 | 2,810,081 | 2,325,376 | |
| Q2 2022 | 1,964,417 | 3,527,203 | 5,491,620 | 791,253 | 486,701 | 1,277,954 | 4,213,666 | |
| Q3 2022 | 3,469,593 | 1,094,111 | 4,563,704 | 3,945,206 | 116 | 3,945,322 | 618,382 | |
| Q4 2022 | 5,732,520 | 3,713,129 | 9,445,649 | 2,652,391 | 0 | 2,652,391 | 6,793,258 | |
| Q1 2023 | 1,163,174 | 805,265 | 1,968,439 | 2,125,896 | 12,375 | 2,138,271 | -169,832 | |
| Q2 2023 | 1,404,525 | 847,066 | 2,251,591 | 3,432,650 | 56,700 | 3,489,350 | -1,237,759 | |
| Q3 2023 | 290,133 | 407,114 | 697,247 | 1,389,547 | 54,900 | 1,444,447 | -747,200 | |
| Q4 2023 | 1,756,728 | 710,855 | 2,467,583 | 1,243,435 | 0 | 1,243,435 | 1,224,148 | |
| Q1 2024 | 1,973,221 | 1,217,590 | 3,190,811 | 1,814,568 | 0 | 1,814,568 | 1,376,243 | |
| Q2 2024 | 1,013,077 | 45,977 | 1,059,054 | 1,331,767 | 0 | 1,331,767 | -272,713 | |
| Q3 2024 | 965,832 | 273,847 | 1,239,679 | 2,050,263 | 0 | 2,050,263 | -810,584 | |